iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
5 hedge funds and large institutions have $4.21M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
54% more capital invested
Capital invested by funds: $2.74M → $4.21M (+$1.47M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$474K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$37.5K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$25 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $3.57M | +$1M | +40,000 | +40% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $483K | +$474K | +18,931 | New |
|
|
AG
3
Advisor Group
Phoenix,
Arizona
| $103K | +$37.5K | +1,498 | +60% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $51K | -$25K | -1,000 | -33% |
|
|
5
Wells Fargo
San Francisco,
California
| – | +$25 | +1 | New |
|
IEIH Hedge Fund Activity: Q2 2019 in Review
5 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q2 2019, worth a combined $4.21M — up 54% from $2.74M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IEIH positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, adding an estimated $1M. The largest seller was Royal Bank of Canada, cutting an estimated $25K.
- 5 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q2 2019, up from 3 in Q1 2019.
- Funds reported $4.21M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q2 2019, up 54% quarter-over-quarter.
- 2 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q2 2019 and 0 closed out, a net change of +2 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q2 2019 was BlackRock, an estimated $1M added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q2 2019 was Royal Bank of Canada, an estimated $25K sold.
Based on aggregated 13F filings for Q2 2019.